SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 1,989.82 |
| Enterprise Value ($M) | 1,785.30 |
| Book Value ($M) | 596.80 |
| Book Value / Share | 10.46 |
| Price / Book | 3.33 |
| NCAV ($M) | 191.07 |
| NCAV / Share | 3.35 |
| Price / NCAV | 10.41 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.16 |
| Return on Assets (ROA) | 0.15 |
| Return on Equity (ROE) | 0.26 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 3.20 |
| Current Ratio | 3.24 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 522.40 |
| Assets | 928.13 |
| Liabilities | 331.33 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Valor IV Pharma Holdings, LLC | |||
| 13G/A | Marshman Fund Trust II | |||
| 13G/A | BlackRock, Inc. | |||
| 13G/A | Vanguard Group Inc | |||
| 13G/A | Fmr Llc | 9.01 | -5.48 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No.1) | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 129,674 | 428,023 | 30.30 | |
| 178,211 | 720,750 | 24.73 | |
| 275,679 | 997,886 | 27.63 | |
| 65,396 | 352,194 | 18.57 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| GANX – Gain Therapeutics, Inc. | GHRS – GH Research PLC |
| HCWB – HCW Biologics Inc. | HROW – Harrow, Inc. |
| IKNA – Ikena Oncology, Inc. |
Financial data and stock pages provided by
Fintel.io